NDC 76045-005-01 - Morphine Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76045-005
- Requested NDC
- 76045-005-01
- Package NDCs from labels
- 76045-005-01, 76045-005-11, 76045-005-02, 76045-005-12
- Manufacturer
- Fresenius Kabi, USA LLC | Fresenius Kabi USA, LLC
- Effective date
- 2026-08-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Morphine Sulfate - Fresenius Kabi, USA LLC | Fresenius Kabi USA, LLC | Fresenius Kabi, USA LLC | Fresenius Kabi USA, LLC | 2026-08-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Morphine Sulfate - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-09-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76045-005-01 | Morphine Sulfate | 1 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION | 1 | 7 | |
| 76045-005-11 | Morphine Sulfate | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76045-005 | MORPHINE SULFATE (MORPHINE SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 17 | Current NDC, Legacy NDC | 20210310_b62ee1ef-db55-417a-a02e-b103890f9c4b.zip |
| 76045-005 | MORPHINE SULFATE INJECTION, SOLUTION [FRESENIUS KABI, USA LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250412_1f53de80-efc8-4930-b3e3-fba0d026af05.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76045-005-01 | ML - Milliliter | 76045-005 | 5c978217-da01-4faa-967c-2d8bbc49ae42 | 1 | 2020-05-08 |
| 76045-005-10 | ML - Milliliter | 76045-005 | 9e55d236-0483-42b1-a9cd-9133d4ab23bd | 1 | 2014-05-02 |
| 76045-005-11 | ML - Milliliter | 76045-005 | 60795206-cf27-4003-b569-ce714cb0a73a | 1 | 2020-05-08 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Calcium Chloride | INACTIVE INGREDIENT | M4I0D6VV5M | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Edetate Disodium | INACTIVE INGREDIENT | 7FLD91C86K | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Trisodium Citrate Dihydrate | INACTIVE INGREDIENT | B22547B95K | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 99c6a1a9-cadf-435b-a332-ccc189afdfa9 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| Anxiety Relief | ACONITUM NAPELLUS, ARGENTUM NITRICUM, ARSENICUM ALBUM, AURUM METALLICUM, GELSEMIUM SEMPERVIRENS, HYOSCYAMUS NIGER, IGNATIA AMARA, KALI CARBONICUM, MOSCHUS, NATRUM MURIATICUM, PIPER METHYSTICUM | NaturalCare | 9f982e89-655c-49be-85d8-4099a02ed021 | 2026-04-15 | Warnings | 451W47IQ8X |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 451W47IQ8X |
| Morphine Sulfate Extended Release | MORPHINE SULFATE | Bryant Ranch Prepack | 2dd52157-3121-41ed-abc2-99b269531e56 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| Anticoagulant Sodium Citrate | TRISODIUM CITRATE DIHYDRATE | LABORATORIOS GRIFOLS SA | db8334be-5b8b-4811-811a-efbe32b6d147 | 2026-04-14 | Warnings | B22547B95K |
| SODIUM CHLORIDE 1 GRAM | SODIUM CHLORIDE | Gendose Pharmaceuticals, LLC | ce988ae5-61c6-4324-90e1-a94c8a54d0d0 | 2026-04-13 | Warnings | 451W47IQ8X |
| MORPHINE SULFATE | MORPHINE SULFATE | Bryant Ranch Prepack | d1b0b4ac-69d9-44bf-b7a3-229bd89b9fd6 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| Quantum Resonance | ALCOHOLUS, ALUMINA SILICATA, ANACARDIUM ORIENTALE, AQUA MARINA, BAPTISIA TINCTORIA, CANDIDA ALBICANS, COLLAGEN, DNA, LAVANDULA OFFICINALIS, MEDULLA OSSIS SUIS, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NUX MOSCHATA, PHOSPHORUS, QUARTZ, SILICEA, TELA ARANEA, VALERIANA OFFICINALIS, VISCUM ALBUM | Deseret Biologicals, Inc. | f94a10bd-1c40-42c7-b458-b58070614549 | 2026-04-10 | Warnings | 451W47IQ8X |
| Quantum Resonance | ALCOHOLUS, ALUMINA SILICATA, ANACARDIUM ORIENTALE, AQUA MARINA, BAPTISIA TINCTORIA, CANDIDA ALBICANS, COLLAGEN, DNA, LAVANDULA OFFICINALIS, MEDULLA OSSIS SUIS, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NUX MOSCHATA, PHOSPHORUS, QUARTZ, SILICEA, TELA ARANEA, VALERIANA OFFICINALIS, VISCUM ALBUM | Deseret Biologicals, Inc. | 1467111a-bef6-473d-b7f2-3309a9bb72ce | 2026-04-10 | Warnings | 451W47IQ8X |
| H-Focus Formula | AGNUS CASTUS, AVENA SATIVA, BARYTA CARBONICA, IGNATIA AMARA, LYCOPODIUM CLAVATUM, NATRUM CARBONICUM, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, SILICEA, ZINCUM METALLICUM | Healing Natural Oils LLC | 4ee42911-3064-7f55-e063-6294a90abcc7 | 2026-04-07 | Warnings | 451W47IQ8X |
| H-Mood Formula | AGRIMONIA EUPATORIA, FLOS, ANACARDIUM ORIENTALE, AURUM METALLICUM, AVENA SATIVA, BORAGO OFFICINALIS, CAPSICUM ANNUUM, CARPINUS BETULUS, FLOS, CIMICIFUGA RACEMOSA, CINCHONA OFFICINALIS, HYPERICUM PERFORATUM, KALI BROMATUM, LARIX DECIDUA, FLOS, NATRUM CARBONICUM, NATRUM MURIATICUM, NATRUM SULPHURICUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA, SILICEA, SINAPSIS ARVENSIS, FLOS, TABACUM | Healing Natural Oils LLC | 4ee5c82e-9edf-c36e-e063-6394a90a237f | 2026-04-07 | Warnings | 451W47IQ8X |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC | 58c24504-47de-487a-ab8d-18add155ea95 | 2026-04-07 | Adverse reactions | 2968PHW8QP |
| Walgreens Sodium Chloride Ophthalmic 5 Percent Hypertonicity Eye | SODIUM CHLORIDE | Walgreen Company | bda3b9db-5fc4-408c-a5ae-d1eeb3ee308d | 2026-04-06 | Warnings | 451W47IQ8X |
| Sodium Chloride Ophthalmic 5 Percent Hypertonicity Eye | SODIUM CHLORIDE | Hanlim | 4ee80e16-1bb1-8238-e063-6294a90aa719 | 2026-04-04 | Warnings | 451W47IQ8X |
| Morphine Sulfate Extended Release | MORPHINE SULFATE | Bryant Ranch Prepack | c94d9da6-7a12-44ee-a38f-3323ee27842c | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| KIDS TOOTHPASTE, FOR CAVITY PROTECTION | KIDS TOOTHPASTE FOR CAVITY PROTECTION | Shulisa (Foshan) Daily ChemicalIndustry Co., Ltd | 4e8fab9e-f05c-5e2f-e063-6294a90aecf9 | 2026-04-03 | Warnings | 059QF0KO0R |
| BACTERIOSTATIC SODIUM CHLORIDE | SODIUM CHLORIDE | Hospira, Inc. | 376093e7-e09e-4a57-3199-195e45251866 | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.